encouraging findings with ribociclib in hr breast cancer
Published 7 years ago • 195 plays • Length 1:24Download video MP4
Download video MP3
Similar videos
-
1:39
frontline endocrine therapies and ribociclib in early stage hr her2- breast cancer
-
1:51
natalee: ribociclib and nsai in hr /her2- early breast cancer
-
2:00
ribociclib in early breast cancer | nejm
-
1:18
findings with abemaciclib plus tamoxifen in advanced breast cancer
-
7:14
ribociclib for hr advanced breast cancer
-
13:54
overall survival results from monaleesa-2: endocrine therapy and ribociclib in hr positive and h...
-
2:26
updated results of the monaleesa-2 trial in hr /her2- breast cancer
-
3:08
adding ribociclib to endocrine therapy shows an improvement in invasive dfs in hr /her2 bc patients
-
2:42
phase ii results for abemaciclib in pretreated hr /her2-negative breast cancer
-
2:46
right choice: ribociclib et vs combo chemo in aggressive hr /her2− advanced breast cancer
-
0:59
dr. kelly on the fda approval of ribociclib in hr breast cancer
-
1:19
monaleesa-2: improved os seen in hr advanced breast cancer treated with ribociclib letrozole
-
3:09
overall survival results from monaleesa-3 study on ribociclib plus fulvestrant in advanced breas...
-
0:36
maintenance w/ et ribociclib after 1l chemotherapy in hr /her2- metastatic breast cancer
-
25:14
metastatic her2 negative breast cancer: emerging novel treatment strategies
-
7:23
study of ribociclib and pdr001 in hr metastatic breast cancer
-
10:15
monaleesa-3 os results: fulvestrant/ribociclib in postmenopausal hr /her2- advanced breast cancer
-
1:25
current state of cdk4/6 inhibitors in metastatic her2-negative breast cancer
-
1:19
advantages to treating hr patients with breast cancer with abemaciclib